MENU

HEPA Hepion Pharmaceuticals Forecast, Technical & Fundamental Analysis

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology
HEPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
HEPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HEPA is expected to report earnings to rise 61.11% to -290 cents per share on May 16

Hepion Pharmaceuticals HEPA Stock Earnings Reports
Q1'23
Est.
$-2.90
Q4'22
Missed
by $1.68
Q3'22
Beat
by $0.06
Q2'22
Missed
by $4.94
Q1'22
Est.
$-0.09
The last earnings report on March 01 showed earnings per share of -179 cents, missing the estimate of -11 cents. With 17.61K shares outstanding, the current market capitalization sits at 3.64M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

HEPA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HEPA has been loosely correlated with AVIR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HEPA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HEPA
1D Price
Change %
HEPA100%
-1.28%
AVIR - HEPA
45%
Loosely correlated
+1.94%
KRYS - HEPA
33%
Poorly correlated
+0.85%
MPSYF - HEPA
28%
Poorly correlated
N/A
PASG - HEPA
25%
Poorly correlated
-7.15%
EXAI - HEPA
23%
Poorly correlated
N/A
More